Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
MSer – A new, neutral descriptor for someone with multiple sclerosis
Imaging of the spine at 3 tesla.
The Safety Profile of Dalfampridine Extended Release in Multiple Sclerosis Clinical Trials.
White matter atrophy and cognitive dysfunctions in neuromyelitis optica.
Accelerometer output and its association with energy expenditure in persons with multiple sclerosis.
Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Asymptomatic Progressive Multifocal Leukoencephalopathy Associated with Natalizumab: Diagnostic Precision with MR Imaging.
Comprehensive Immunophenotyping of Cerebrospinal Fluid Cells in Patients with Neuroimmunological Diseases.
Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis.
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Psychological effects of calisthenic exercises on neuroinflammatory and rheumatic diseases.
Disclosing the diagnosis of multiple sclerosis: The Profile Project.
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis.
[Gluten-related disorders and demyelinating diseases.]
Evaluation of olfactory dysfunction in neurodegenerative diseases.
Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis.
Shifting imaging targets in multiple sclerosis: From inflammation to neurodegeneration.
Optic Neuritis Probably Induced by Isotretinoin.
A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis.
Progressive multifocal leukoencephalopathy: new concepts.
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Pages
« first
‹ previous
…
195
196
197
198
199
200
201
202
203
…
next ›
last »